HER2DX is the world’s first diagnostic test formulated specifically for HER2-positive (HER2+) breast cancer. HER2DX analyzes RNA on 27 genes…
featured news
For yet another year, researchers from the Vall d’Hebron Institute of Oncology (VHIO), which is part of the Vall d’Hebron…
